Share-based Payment Arrangements (Tables)

3 Months Ended

Apr. 01, 2023

Amounts Recognized in Financial Statements with Respect to Plans

Amounts recognized in the financial statements with respect to these Plans are as follows (in thousands):

	Thirteen Weeks Ended
	April 1, 2023			March 26, 2022
Total cost of the Plans during the period	$	1,852		$	1,995
Amount of related income tax benefit recognized during the period		(2,751	)		(3,360	)
Net cost of the Plans during the period	$	(899	)	$	(1,365	)

Schedule of Information on Restricted Stock Units

The following table summarizes information regarding the Company’s outstanding restricted stock unit (“RSU”) awards with either a performance condition or a market condition under the Plans:

 

	Number of RSUs			Weighted Average Grant Date Fair Value
Outstanding at December 31, 2022		151,780		$	115.80
Granted		41,162		$	165.29
Shares earned in excess of target (1)		74,418		$	101.31
Vested shares, including shares earned in excess of target		(125,652	)	$	102.37
Outstanding at April 1, 2023		141,708		$	134.47

(1) Represents additional shares earned under each of the February 1, 2019 and January 31, 2020 RSU awards, as fiscal year 2022 financial results exceeded target performance level.

Schedule of Information on Non-Vested Restricted Stock and Deferred Stock Units

The following table summarizes information regarding the Company’s outstanding shares of non-vested restricted stock and Deferred Stock Units (defined below) under the Plans:

	Number of Shares and Deferred Stock Units			Weighted Average Grant Date Fair Value
Non-vested at December 31, 2022		47,795		$	138.30
Granted		16,757		$	180.42
Vested		(16,857	)	$	131.56
Non-vested at April 1, 2023		47,695		$	155.48